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Objective: The focus of tissue engineering of neocartilage has traditionally been on enhancing extrac-
ellular matrix and thus biomechanical properties. Emphasis has been placed on the enhancement of
collagen type and quantity, and, concomitantly, tensile properties. The objective of this study was to
improve crosslinking of the collagen network by testing the hypothesis that hypoxia could promote
pyridinoline (PYR) crosslinks and, thus, improve neocartilage’s tensile properties.
Methods: Chondrocyte expression of lysyl oxidase (LOX), an enzyme responsible for the formation of
collagen PYR crosslinks, was ﬁrst assessed pre- and post- hypoxia application. Then, the mechanical
properties of self-assembled neocartilage constructs were measured, after 4 weeks of culture, for groups
exposed to 4% O2 at different initiation times and durations, i.e., during the 1st and 3rd weeks, 3rd and
4th weeks, 4th week only, continuously after cell seeding, or never.
Results: Results showed that LOX gene expression was upregulatedw20-fold in chondrocytes in response
to hypoxia. Hypoxia applied during the 3rd and 4th weeks signiﬁcantly increased PYR crosslinks without
affecting collagen content. Excitingly, neocartilage tensile properties were increased w2-fold. It should
be noted that these properties exhibited a distinct temporal dependence to hypoxia exposure, since
upregulation of these properties was due to hypoxia applied only during the 3rd and 4th weeks.
Conclusion: These data elucidate the role of hypoxia-mediated upregulation of LOX and subsequent in-
creases in PYR crosslinks in engineered cartilage. These results hold promise toward applying hypoxia at
precise time points to promote tensile integrity and direct construct maturation.
 2013 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.Introduction
Articular cartilage (AC) pathologies, resulting from injury/
trauma or age-related degeneration, are major health problems in
the developed world. Osteoarthritis (OA) is the most frequent
chronic musculoskeletal disease, limiting daily activities of the
elderly1. Over the past two decades, progress has been made on the
development of therapeutic approaches for the treatment of early
stage cartilaginous defects, thus slowing down their progression to
OA. However, current therapeutic procedures including washing,
shaving and debridement, stem cell stimulation-based procedures,
and explant grafts have thus far proved to be incapable to effect
long-term repair2. Tissue engineering has the potential to generateK.A. Athanasiou, Department
Davis, One Shields Avenue,
30-754-5739.
Makris), jcyhu@ucdavis.edu
s Research Society International. Ptissue with biomechanically competent extracellular matrix (ECM)
in vitro3. However, limitations in the development of neotissues
that mimic the structural composition and, hence, biomechanical
behavior of native tissues present a great challenge4. To generate
neotissues capable of bearing physiological loads, various exoge-
nous stimuli during neocartilage culture have been examined.
In engineering cartilage, hypoxia has been proposed for both
stem cells and differentiated chondrocytes. For stem cells, hypoxia
has been reported to promote chondro-differentiation5e7 and to
impede hypertrophy8. Hypoxia inducible factor 1 (HIF-1) has been
hypothesized as critical for hypoxic induction of chondrogenesis8.
For engineering AC, however, hypoxia has shownmixed results. For
instance, some studies have suggested that Sox-9 expression is
largely independent of hypoxia9, while others have shown that this
transcription factor increases with reduced oxygen levels10.
Likewise, ECM components (e.g., aggrecan, collagen type II, pro-
teoglycan 4) have been shown to be upregulated with hypoxia in
certain cases10,11, while others have shown that cartilaginous ECM
production is indifferent to hypoxia12 or even suppressed by it in
certain instances13,14. In brief, though the majority of evidenceublished by Elsevier Ltd. All rights reserved.
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cartilage constructs, mechanisms behind such improvements have
largely remained elusive. For hypoxia to be used efﬁciently and
reliably in cartilage tissue engineering, a robust mechanistic con-
nection between hypoxia and mechanical properties must be
determined.
In the human body, normal oxygen tension, or normoxia, is
between 5% and 13%15. Oxygen levels lower than 5% are considered
hypoxic16, while the atmospheric oxygen tension of 21% should be
considered hyperoxic17. For differentiated chondrocytes, oxygen
tension can be as low as 1e2.5%, thus qualifying cartilage as func-
tioning under a hypoxic environment14. Thus, oxygen concentra-
tion during in vitro culture likely needs to be below 5% to induce
signiﬁcant HIF-1a stabilization and its subsequent upregulation of
various matrix-associated genes.
The anisotropic, structural and mechanical properties of AC,
including its well-developed, collagen ﬁber architecture, determine
tissue functionality andmechanical integrity18. Apart from collagen
content and organization, the load-bearing capacity of collagen is
related to other ECM components. Two features that directly in-
ﬂuence native AC stiffness and determine collagen maturity are the
type and quantity of collagen crosslinks19,20. Thus far, these critical
features have not been sufﬁciently mimicked in the ECM of engi-
neered tissues; lack of progress on this front may be a factor for the
current limitations in tissue modulus and strength19,21. An oppor-
tunity exists in the modulation of collagen crosslinking in engi-
neered neocartilage to enhance tissue structural and functional
integrity. While hypoxia has been associated with collagen cross-
linking in several other tissues22e24, its use for inducing crosslinks
in engineered cartilage remains unexplored.
In this study, engineered cartilage is formed using a scaffoldless,
self-assembling process that removes the potentially confounding
effects of scaffolds. The objectives of this study are to examine two
hypotheses: (1) that hypoxia (4% oxygen) will enhance the me-
chanical properties of engineered AC by mediating collagen cross-
linking via lysyl oxidase (LOX), and (2) this speciﬁc response to
hypoxia is dependent on application time.
Methods
Chondrocyte isolation
AC was sterilely harvested from the distal femur of knee joints
obtained from 1-week-old calves (Research 87, Boston, MA, USA).
Tissue was minced into 1 mm pieces and digested in 0.2% collage-
nase type II (Worthington, Lakewood, NJ, USA) for 18 h in cell culture
medium (Dulbecco’s modiﬁed Eagle’s medium (DMEM) with low
glucose (1 g/L)) (Life Technologies corp., Carlsbad, CA, USA),10% fetal
bovine serum (FBS) (Atlanta Biologicals), 1% non-essential amino
acids (NEAA) (Life Technologies corp., Carlsbad, CA, USA), 25 mg of
L-ascorbic acid (SigmaeAldrich, St. Louis, MO, USA), and 1% pen-
icillin/streptomycin/fungizone (PSF) (BioWhittaker Inc., Walkers-
ville,MD, USA). After digestion, articular chondrocyteswerewashed
three times in PBSwith centrifugation and ﬁltered through a 70-mm
ﬁlter. Cells then were counted and were frozen at 80C in culture
medium supplemented with 10% FBS and 10% dimethyl sulfoxide
(Fischer Scientiﬁc, Pittsburgh, PA, USA). Cells were stored in liquid
nitrogen until used.
Construct formation via the self-assembling process
Constructs were generated by seeding articular chondrocytes
into cylindrical, non-adherent wells using a technique adapted
from previous work3,25. A stainless steel mold consisting of 5 mm
diameter cylindrical prongswas placed intomolten 2% agarose (LifeTechnologies corp., Carlsbad, CA, USA) in a 48-well plate. The
agarose solidiﬁed at room temperature, and themoldwas removed.
Two changes of control medium (DMEM with GlutaMAX (Life
Technologies corp., Carlsbad, CA, USA), 100 nM dexamethasone
(SigmaeAldrich, St. Louis, MO, USA), 1% NEAA, 1% PSF, 1% ITSþ
premix (BD Scientiﬁc, Franklin Lakes, NJ, USA), 50 mg/mL ascor-
bate-2-phosphate (SigmaeAldrich, St. Louis, MO, USA), 40 mg/mL
L-proline (SigmaeAldrich, St. Louis, MO, USA), and 100 mg/mL so-
dium pyruvate (Fischer Scientiﬁc, Pittsburgh, PA, USA)) were used
to saturate the agarose before cell seeding. Following isolation,
articular chondrocytes were thawed within 5 days of freezing.
Viability assessed using trypan blue was >90%. To create each
construct, 5.5 million cells in 100 ml control medium were seeded
into each gelled, cylindrical agarose well, followed by addition of
400 ml control medium after 4 h. Cells coalesced into free-ﬂoating,
disc-shaped constructs upon the non-adhesive agarose; t ¼ 1 day
was deﬁned as 24 h after seeding. Constructs were cultured in the
agarose wells until t ¼ 10 days, at which point they were uncon-
ﬁned transferred to 48-well plates where theywere unrestricted by
circumferential conﬁnement. Constructs received 500 ml medium
change every 24 h and remained in culture until t ¼ 28 days.Hypoxia application
Following seeding, constructs were divided into ﬁve treatment
groups. Constructs in the ﬁrst group (control) were incubated con-
tinuously at 37C, 5% CO2, and 21% O2. Constructs from the other
groups were incubated under the same conditions but also
treated with 4% O2 (hypoxia) during the following culture periods:
t ¼ 1e7 days and 15e21 days (1st and 3rd weeks), t ¼ 15e28 days
(3rd and 4th weeks), t ¼ 22e28 days (4th week), and t¼ 1e28 days
(continuous hypoxia). Every other day, 500 ml of medium was
changed. After 4weeks of culture, constructsweredivided intoparts
for histological, biochemical, and biomechanical assessments.Histology
Samples of the neotissue were cryoembedded in Histoprep
(Fisher Chemical, Vernon Hills, IL, USA) and sectioned at 14 mmwith
orientation from top to the bottom of the construct, in all groups.
Following sectioning, samples were ﬁxed in formalin for 15 min.
Qualitative evaluation of collagen and glycosaminoglycan (GAG)
content of the samples was performed by using Safranin-O/fast
green and Picrosirius red stains as previously described26. Pheno-
type maintenance of articular chondrocytes was evaluated with
immunohistochemistry (IHC). Brieﬂy, samples were ﬁxed in chilled
(4C) acetone, rehydrated, and stained for collagen type I and II by
following protocols provided by Chondrex and Vectastain as pre-
viously described26. Native bovine AC and patellar tendon were
used as positive type II and type I controls, respectively.Quantitative biochemistry
Biochemical samples were lyophilized, and dry weight was
recorded. Subsequently, samples were digested using a pepsin-
elastase protocol as previously described26. Collagen content in
the engineered tissue was evaluated using a colorimetric hydroxy-
proline assay27. A Blyscan Glycosaminoglycan Assay kit (Biocolor,
Newtownabbey, Northern Ireland) was used for sulfated GAG con-
tent quantiﬁcation28,29. Cell content in the engineered tissue was
approximated using a Picogreen dsDNA reagent (Molecular Probes,
Eugene, OR, USA) for DNA quantiﬁcation and a conversion factor of
7.7 pg DNA/cell.
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The abundance of pyridinoline (PYR) crosslinks in the engi-
neered tissue was quantiﬁed using HPLC. Portions of the constructs
were weighed wet, digested in 400 ml 6 N HCl, and dried in a vac-
uum concentrator. 50 mL of an aqueous solution containing 10 nmol
pyridoxine/mL and 2.4 mmol homoarginine/mL was used for sam-
ple re-suspension and then diluted 5-fold with an aqueous solution
of 0.5% heptaﬂuorobutyric acid (HFBA) in 10% acetonitrile. Fol-
lowing this, 50 mL of each sample was injected into a 25 mm C18
column (Shimadzu, Columbia, MD, USA) and eluted using a solvent
proﬁle as previously described30. A calibration curve was per-
formed using PYR standards (Quidel, San Diego, CA, USA) for
crosslink quantiﬁcation.
Compression testing
The compressive properties of the constructs were evaluated
with creep indentation testing as previously described3. A 0.7 g
(0.007 N) mass was applied through a 0.45 radius ﬂat, porous
indenter tip on each sample stabilized to a stainless steel surface.
Compressive properties of the neocartilage, represented by aggre-
gate modulus, permeability and Poisson’s ratio were calculated by
adapting a semi-analytic, semi-numeric, linear biphasic model31.
Tensile testing
A uniaxial material testing apparatus (Instron, model 5565;
Canton, MA, USA) (Instron Model 5565) was used to quantify the
tensile properties of the constructs as previously described26. Each
specimenwas prepared by cutting it into a dog-bone shapewith a 1-
mm-long gauge length. Photographs were taken of each specimen
and thickness and width were determined using ImageJ software.
Uniaxial tension until failure within the gauge length at a strain rate
of 1% of the gauge length per second was performed using a 5 kN
load cell. Force-displacement curves were generated, and stresse
strain curves were calculated by normalizing data to specimen
dimension. The apparent Young’s modulus, a measure of specimen
tensile stiffness, was determined by least squares ﬁtting of the linear
region of the stressestrain curve. The ultimate tensile strength
(UTS) was determined as the maximum stress reached during a test.
RT-PCR
Real-time PCR analysis was performed to investigate hypoxia-
mediated gene expression of the target genes. Dynamic changes
in LOX expression can occur during the ﬁrst 18 h of a culture’s
introduction to hypoxia17,32. In order to observe LOX expression at
steady state, measurements within the short time period imme-
diately after hypoxia exposure were avoided. On the other hand,
since LOX-induced crosslink formation can require weeks to
mature, it was desirable to assess for LOX expression as early as
possible. Thus, hypoxia was applied in 3 week-engineeredTable I
Growth metrics and biochemical content of 4 weeks neocartilage constructs*
Groups Diameter (mm)
(P ¼ 0.4645)
Thickness (mm)
(P ¼ 0.2384)
W
(
Control 5.21  0.22 1.53  0.11 2
1st & 3rd weeks 5.17  0.33 1.35  0.25 2
3rd & 4th weeks 5.11  0.23 1.40  0.22 2
4th week 5.09  0.33 1.48  0.42 2
Continuous 5.20  0.24 1.45  0.35 2
* The effects of hypoxia as a function of application time during the self-assembly of
groups) were examined on gross morphology (diameter, thickness, andWW) and biochem
mean  95% CI. No signiﬁcant differences were detected among controls and hypoxia-trneocartilage for 2 days and the gene expression of LOX was quan-
tiﬁed as previously described17. S18 (housekeeping gene) and LOX
primers were purchased from US Biological. RT was performed by
incubating 500 ng of RNA with SuperScript III (Life Technologies
corp., Carlsbad, CA, USA) as recommended by the manufacturer.
Real-time PCR was done using SYBR Green mastermix and 1 mm
primers on a Rotor-gene 3000 real-time PCR machine (Corbett
Research, Bath, UK). A 10 min denaturing step was employed, fol-
lowed by 45 cycles of 95C (15 s) and 60C (60 s). The take-off cycle
(CT) for each gene of interest (GOI) was compared to the house-
keeping gene GAPDH. Relative gene expressions were calculated
using the 2DDCT method.
Statistical analysis
All biochemical and mechanical assessments in this study were
performed using n ¼ 5e8 samples per group. Numerical data are
represented as mean  95% conﬁdence interval for the mean
(95% CI). The presence of outliers was determined using either
Grubb’s test and/or by noting testing abnormalities (e.g., failure at
the grips during tensile testing). Prior to performing statistical
tests, the data were checked for both normality and equal-
variance using Levene’s test. To compare among treatment
groups, one-way analysis of variance (ANOVA) was performed us-
ing StatView software (StaView inc Cary, Nesbit, MS, USA). If sig-
niﬁcance was identiﬁed, Fisher’s post hoc testing was applied.
Unequal sample sizes were addressed by non-parametric all-pairs
multiple comparisons based on pairwise rankings in the one-way
design with the SteeleDwass procedure. P-values less than 0.05
were considered signiﬁcant.
Results
Gross morphology and histology
At the end of the culture period the morphological properties
and composition of the engineered constructs were assessed via
gross inspection and histological evaluation. All constructs pre-
sented with similar ﬂat surfaces without abnormalities and no
signiﬁcant differences were detected in morphology among the
groups. Table I describes morphological characteristics (diameter,
thickness, and wet weight (WW)) of the constructs. Histology
showed that all constructs stained uniformly positive for both GAG
and collagen content (Fig. 1). Additionally, IHC showed that neo-
cartilage from all groups stained positive for collagen type II and
negatively for collagen type I proving normal AC phenotype
maintenance in all groups (Fig. 1).
Biochemical properties
Growth of the constructs was evaluated through assessment of
the amount of collagen, GAG, DNA, and PYR of neotissue at the
end of the culture period. Table II describes the biochemicalet weight (mg)
P ¼ 0.4566)
Water content (%)
(P ¼ 0.7472)
Cell number (millions)
(P ¼ 0.2669)
9.87  4.93 88.75  13.23 3.01  2.86
9.65  8.80 90.50  12.11 4.03  3.26
6.45  2.06 87.46  7.93 4.24  5.22
8.30  7.42 87.81  9.52 4.46  4.39
8.09  10.95 88.19  5.43 2.64  2.22
AC (control, 1st & 3rd weeks, 3rd & 4th weeks, 4th week, and continuous hypoxia
ical properties (water content and cell number) after 4 weeks of culture. Values are
eated groups. See Results section for details. Col ¼ collagen.
Fig. 1. Gross morphology, histology, and IHC of self-assembled neocartilage. Both controls and hypoxia-treated constructs formed uniform neocartilage constructs with similar ﬂat
surfaces without physical abnormalities. The orientation of cryosectioning was from top to bottom in all groups (14 mm sections). Safranin-O/fast green staining for GAGs and
Picrosirius red staining for collagen showed that constructs produced these matrix components uniformly for all groups. IHC illustrated that all groups were positive stained for
collagen type II but not for collagen type I, suggesting AC phenotype. For gross morphology (top row), each notch represent 1 mm. For histology, bar represents 200 mm.
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detected in GAG per wet weight (GAG/WW) among the groups
(P ¼ 0.718). For collagen per wet weight (Col/WW), no signiﬁcant
differences were detected among control, and late hypoxia appli-
cation groups (3rd and 4th weeks, and 4th week group) (P¼ 0.2716
and P ¼ 0.9919, respectively). Interestingly, constructs treated with
hypoxia at an early stage (1st and 3rd weeks and all weeks groups)
presented with signiﬁcantly lower amount of collagen over control
and late treated groups (P ¼ 0.004 and P ¼ 0.004).
Hypoxia applied during 3rd and 4th weeks signiﬁcantly
increased the amount of PYR/WW over controls (34% increase)
(P ¼ 0.003), while no signiﬁcant effects were detected on the other
applied groups over controls (P ¼ 0.4160, P ¼ 0.9753, and
P ¼ 0.9991 for 1st and 3rd weeks, 4th week and continuous groups,
respectively) (Table II). In contrast, when PYR content was nor-
malized to collagen content (PYR/Col), early application of hypoxia
(1st and 3rd weeks, continuous groups) exhibited the highest
amount of collagen crosslinks (P < 0.001 and P ¼ 0.001, respec-
tively) (Table II). For the 3rd and 4th weeks group, the amount of
PYR/Col was also signiﬁcantly higher over controls (P ¼ 0.0499),
while in the 4th week group no signiﬁcant differences were
detected (P ¼ 0.4583).Table II
Biochemical properties of self-assembled neocartilage*
Groups Collagen/WW %
(P < 0.0001)
GAG/WW %
(P ¼ 0.718)
Control 3.03  0.61A 4.39  2.10
1st & 3rd weeks 1.93  1.27B 3.84  3.85
3rd & 4th weeks 3.33  1.23A 4.96  3.44
4th week 3.03  1.50A 4.91  3.50
Continuous 1.91  0.44B 4.44  2.96
* Biochemical properties of the engineered neocartilage as represented by Col/WW, GAG
applied if P < 0.05. Groups not connected by the same letter are signiﬁcantly different. SBiomechanical properties
To quantify the inﬂuence of low oxygen tension applied at dif-
ferent time periods on the biomechanics of self-assembled neo-
cartilage, compressive properties represented by the aggregate
modulus, permeability, and poison’s ratio, and tensile properties
represented by Young’s modulus (EY) and UTS and were deter-
mined. No signiﬁcant difference was detected for compressive
properties among groups (P ¼ 0.4017, P ¼ 0.1101, and P ¼ 0.3124 for
aggregate modulus, permeability, and Poisson’s ratio, respectively)
(Table III). Low oxygen tension applied during 3rd and 4th weeks of
the self-assembling process signiﬁcantly increased the tensile
stiffness of the constructs over controls (w80% increase)
(P < 0.0001). Similar trends were observed concerning the UTS of
the constructs (Table III). Enhancedmechanical properties reﬂected
the observed changes in the PYR content.
RT-PCR
Real-time PCR was employed to investigate the effects of hyp-
oxia in the engineered neocartilage using the self-assembly
method. Application of hypoxia in the neotissue promoted anPYR/WW (nmol/g)
(P ¼ 0.0036)
PYR/Col (nmol/mg)
(P < 0.0001)
4.99  1.86B 0.16  0.030D
5.68  1.00A,B 0.30  0.169A
6.63  1.90A 0.20  0.034C
5.19  1.06B 0.17  0.105C,D
5.08  1.88B 0.26  0.063B
/WW, PYR/WWand PYR/Col. Values aremean 95% CI. Fisher’s post hoc testing was
ee Results section for details. Col ¼ collagen.
Table III
Biomechanical properties of the engineered neocartilage*
Group Aggregate modulus (MPa)
(P ¼ 0.4017)
Permeability (1015 m4/N’s)
(P ¼ 0.1101)
Poisson’s ratio
(P ¼ 0.0773)
Young’s modulus (MPa)
(P < 0.0001)
UTS (MPa)
(P ¼ 0.4600)
Control 0.11  0.06 18.50  15.69 0.09  0.22 0.45  0.23B,C 0.07  0.04
1st & 3rd weeks 0.10  0.06 16.85  16.89 0.08  0.02 0.19  0.23C 0.11  0.07
3rd & 4th weeks 0.12  0.05 11.62  9.68 0.05  0.11 0.82  0.53A 0.06  0.09
4th week 0.13  0.04 16.04  8.70 0.01  0.02 0.53  0.54A,B 0.11  0.11
Continuous 0.11  0.06 24.98  28.31 0.06  0.12 0.25  0.19B,C 0.18  0.18
* Compression properties of tissue engineered neocartilage constructs represented by aggregate modulus, permeability, and Poisson’s ratio, and tensile properties rep-
resented by Young’s modulus and UTS. Values are mean  95% CI. Fisher’s post hoc testing was applied if P < 0.05. Groups not connected by the same letter are signiﬁcantly
different. See Results section for details.
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tured under normoxic conditions.
Discussion
This is the ﬁrst study to demonstrate that hypoxia’s effect on
enhancing engineered cartilage’s tensile properties is through
collagen crosslinking. Experimental data proved both hypotheses
motivating the study, showing (1) hypoxia is a viable method for
promoting collagen crosslinking in engineered tissue through LOX
gene expression and (2) distinctly different responses can be eli-
cited by this stimulus by manipulating application time and dura-
tion. Hypoxia can be restricted to inﬂuence only the tensile
properties of the constructs, while other neocartilage properties
such as gross morphology, collagen and GAG biochemistry, and
compressive stiffness remain unaltered. By determining a method
wherein hypoxia can be isolated to act only through collagen
crosslinks, this study provides a robust method for improving the
tensile properties of engineered cartilage that has the potential to
be extended to other engineered tissues.
In this study, hypoxia was applied in tissue engineered AC to
enhance crosslinking by promoting gene expression of LOX. Low
oxygen tension (4% O2) applied during the 3rd and 4th weeks of
self-assembly of neocartilage signiﬁcantly increased the amount of
PYR molecules (PYR/WW and PYR/Col) over controls and the other
treated groups with concomitant increase in the gene expression of
LOX (18-fold) over controls. In contrast, no signiﬁcant differences
were observed among the 3rd and 4th weeks, the 4th week and
control groups for collagen, GAG and DNA content per WW. Addi-
tionally, hypoxia applied during the 3rd and 4th weeks increased
the tensile stiffness of neocartilage by approximately 80% over
controls (P< 0.0001). These results demonstrate that application of
hypoxia can be directed to promote collagen crosslinking and
enhance the tensile properties in engineered cartilage, independ-
ently of other biochemical and biomechanical properties.
In contrast, hypoxia applied during times other than the 3rd and
4th weeks did not result in improved properties. At times, these
properties were diminished, shedding light onto the mixed results
seen in the cartilage engineering literature that employ hypoxia.
Early application of hypoxia (1st and 3rd weeks and continuous
application groups) signiﬁcantly increased the PYR/Col content, but
collagen content was diminished simultaneously. Early hypoxia
application allowed for a more time for collagen crosslinking to
form. For reference, the characteristic time constants for the for-
mation of immature (difunctional) and mature (trifunctional) PYR
crosslinks have been reported to be 1e2 and 7e30 days, respec-
tively33. However, early hypoxia application also signiﬁcantly
decreased the collagen content of neotissue at these groups. The
net effect is that early hypoxia application did not increase PYR/
WW, and the mechanical properties of neotissue remained un-
changed. Biochemical evaluation further showed no signiﬁcant
differences in terms of the number of cells per construct and GAG/WW in these groups. Thus, it appears that early hypoxia application
is actually detrimental to engineering self-assembled cartilage
when it is applied during a time previously identiﬁed as the col-
lagen synthesis phase25.
These results are similar to a previous study investigating the
effects of 5% and 20% O2 applied continuously for 2, 4 and 6 weeks
in a scaffold-free chondrocyte culture13. In this study, engineered
cartilage from scaffold-free cultured chondrocytes at 20% O2 pro-
duced better ECM than that at 5% O2. Thus, the present study offers
an examination on the conﬂicting results currently seen with
hypoxia; hypoxia applied during the collagen synthesis phase of
engineered cartilage can diminish collagen production and there-
fore adversely affect construct biomechanical properties. Use of
hypoxia to induce crosslinking should instead be employed after
collagen is already present. This time dependence issue should be
further investigated in other cartilage engineering approaches.
In three-dimensional cultures or engineered tissues, work on
studying the effects of different oxygen concentrations might be
impaired by poor oxygen diffusion that creates an oxygen gradient
within tissue34. Additionally, HIF-1a protein is very unstable at the
environmental oxygen level while its mRNA is not affected by
hypoxic conditions16. This makes it difﬁcult to demonstrate,
experimentally, that the HIF-1a protein increases in response to
hypoxia. However, the link between hypoxia, LOX gene expression,
and LOX-mediated collagen crosslinking has been explored inmany
other tissues17,23,25,35. Speciﬁcally, growth of porcine aortic endo-
thelium cells in 0% or 2% oxygen tension resulted in little change in
cell numbers or cell protein, but a fall in collagen synthesis and in
proline and lysine hydroxylases, as well as a rise in LOX gene
expression,were observed35. Similarly, the crosslinkpattern and the
gene expression of lysyl hydroxylase 2 (LH2) were investigated us-
ing skin cells fromsystemic scleroderma, culturedunder lowoxygen
tension conditions. Prolongedhypoxia induced amarked increase of
the mRNA level of LH2 in relation to collagen I22. Thus, the use of
hypoxia to promote LOX- and LH-mediated collagen crosslinking
can be considered as a robust mechanism and this experiment
showed not only that hypoxia can be used in engineering cartilage,
but that its effects can be isolated to tensile properties only.
Further proof of the robustness of the hypoxia-tensile rela-
tionship can be seen in engineering other tissues17,34,36. It has been
reported that 7% O2 applied in human vascular-derived myoﬁbro-
blasts seeded onto a biodegradable scaffold similarly increases
construct properties as seen in this study36. In another case, 4% O2
enhanced gene expression of LOX and LH217. It is, thus, conceivable
that the use of hypoxia can be translated to other musculoskeletal
tissues. The ECM of native ligaments, tendons, bone, and other
musculoskeletal tissues is composed of proteoglycans and ﬁbrillar
proteins, such as elastin and collagen. The load-bearing capacity of
collagen is, apart from collagen content and organization, highly
dependent on collagen crosslinking, which stabilizes the collagen
ﬁbrils37. The in vitro formation of these highly important ECM
components can be affected by mechanical, biochemical, and
E.A. Makris et al. / Osteoarthritis and Cartilage 21 (2013) 634e641 639environmental stimuli, such as oxygen concentration36,38,39. As
with this experiment, hypoxia could potentially improve the me-
chanical properties of other engineered musculoskeletal tissues
through collagen crosslinking enhancement. However, application
time for these engineered tissues must be optimized as to restrict
its effects on crosslinks only.
Due to HIF-1a’s link with other ECM gene expression, this study
provides strong support for further development of other hypoxia
duty cycles. Speciﬁcally, hypoxia may be applied during certain
times to encourage proper differentiation, switching to normoxia to
induce collagen synthesis, and returning to hypoxia to promote
crosslinking. The motivation that underlies such a duty cycle can be
found in multiple studies. For stem cells, hypoxia, through HIF-1a
overexpression, has been shown to be effective and sufﬁcient in
inducing a chondrocytic phenotype on human bone marrow stem
cells without use of exogenous growth factors40. Similar results
have been obtained with adipose-derived stem cells41. While
hypoxia seems beneﬁcial for chondrodifferentation, early applica-
tion during neocartilage tissue engineering does not result in
improved properties as demonstrated by this and prior work13.
Thus, the present study provides strong support for further devel-
opment of other hypoxia duty cycles, suggesting that, until robust
mechanisms can be determined for hypoxia’s effects on ECM syn-
thesis, this potent stimulus should only be applied for differentia-
tion and for collagen crosslinking.
Aside from PYR, other cartilage crosslinks such as arginoline and
advanced glycation end products (AGEs) might similarly be
manipulated to inﬂuence neocartilage stiffness. Arginoline makes
up for half of the mature crosslinks in native cartilage42 but cannot
be measured via HPLC, necessitating future studies on its charac-
terization in engineered tissues. AGEs occur over a time-scale of
decades as sugars react with the lysine and arginine residues
during aging. Examples of common AGEs include crosslinks, such
as pentosidine43e45, methylglyoxal-lysine dimer (MOLD)44, and
threosidine46, as well as Nε-(carboxymethyl)lysine (CML)47 and Nε-
(carboxyethyl)lysine (CEL)48. Though past work has correlated
AGEs with stiffening of the collagen matrix49, AGEs have also been
implicated in the progression of age-related cartilage degeneration
such as OA50. AGEs may thus be an inferior candidate when com-
pared to PYR and arginoline for enhancing neocartilage mechanical
properties.
In this experiment, low oxygen tension (4% O2) was investigated
at various application times during the self-assembling process
both to identify optimal regimens for hypoxia application and to
elucidate a mechanism through which hypoxia-induced increases
in cartilage mechanical properties occur. Hypoxia applied during
the collagen synthesis phase resulted in decreased collagen con-
tent. However, hypoxia applied later in culture served to induce
LOX expression, crosslink formation, and increased tensile prop-
erties. Strong evidence from both this study and a plethora of prior
studies suggest that this occurs through the robust mechanism of
HIF-1a-induced upregulation of LOX. The results shown here are
promising as they show that hypoxia can be used to tissue engineer
neocartilage with robust tensile properties. In the future, while one
may consider the possibility of employing hypoxia to achieve
similar biomechanical improvements in cartilage just showing
signs of mechanical degradation, a different regimenwill have to be
identiﬁed for intra-articular regulation of oxygen tension. Addi-
tionally, hypoxia may be beneﬁcial for enhancing the mechanical
properties of autografts or allografts.
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